JPRN-UMIN000004088已完成未知
Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC - Efficacy and safety of response-guided pegylated-interferon alpha-2a mono therapy in hemodialysis patients with chronic hepatitisC
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 50
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18years-old 至 70years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The following patients were excluded 1)Allegic history to interferon preparations 2)Autoimmune hepatitis,alcoholic liver injury,or chronic liver diseases with other underlying causes 3)Liver cirrhosis,decompensated liver diseases 4) Abnormal thyroid function 5)Concomitant herbal medication of Sho-saikoto 6) history of interstitial pneumonia 7) Women of childbearing potential and pregnancy, lactating woman 8)severe depression 9)Allergic to vaccine or biological preparations 10)Other conditions considered inappropriate by attending physician
研究者
相似试验
进行中（未招募）
1 期
Efficacy and safety of pegylated-proline-interferon alpha 2B (AOP2014) in maintaining deep molecular remissions in patients with chronic myeloid leukemia who discontinue ABL-kinase inhibitory therapy, with post-study follow-up.Chronic myeloid leukemiaMedDRA version: 21.0Level: LLTClassification code 10009016Term: Chronic myeloid leukemia in remissionSystem Organ Class: 100000004864EUCTR2016-001030-94-DEPhilipps University Marburg210
进行中（未招募）
1 期
Efficacy and safety of pegylated-proline-interferon alpha 2B (AOP2014) in maintaining deep molecular remissions in patients with chronic myeloid leukemia who discontinue ABL-kinase inhibitory therapy, with post-study follow-up.EUCTR2016-001030-94-FRPhilipps University Marburg214
已完成
不适用
Investigation of the efficacy and safety of ipragliflozin in obese patients with type 2 diabetes undergoing metformin (Met)Type 2 diabetesJPRN-UMIN000014638Association of medical corporation Toyukai, Yutenji Medical Clinic35
已完成
不适用
Investigation of the efficacy and safety of ipragliflozin combination therapy in case of insufficient glycemic control by DPP-4 inhibitorsType 2 diabetesJPRN-UMIN000014790Japan Community Health care Organization Kanazawa Hospital30
招募中
2 期
Study of pretransplant conditioning with PK-guided intravenous busulfaJPRN-jRCTs051200020Kanda Junya80